Citations

Clear

861 citation(s) found for "Sd, Wexner".

Biceps Tenodesis for Superior Labrum Anterior-Posterior Tear in the Overhead Athlete: A Systematic Review
Frantz, Travis L. , Shacklett, Andrew G., Martin, Adam S. , Jones, Grant L. , Neviaser, Andrew S. , Cvetanovich, Gregory L. , Barlow, Jonathan D.

Mayo Clinic

The American Journal of Sports Medicine | June 24, 2020 | Volume: 49 | Issue: 2 | Pages: 522-528

10.1177/0363546520921177 | PMID 32579853 Get It

Background: Superior labrum anterior-posterior (SLAP) lesion is a common shoulder injury, particularly in overhead athletes. While surgical management has traditionally consisted of SLAP repair, high rates of revision and complications have led to alternative techniques, such as biceps tenodesis (BT). While BT is commonly reserved for older nonoverhead athletes, indications for its use have expanded in recent years. Purpose: To determine functional outcomes and return-to-sport rates among overhead athletes after BT for SLAP tear. Study Design: Systematic review. Methods: A systematic review was performed for any articles published before July 2019. The search phrase “labral tear” was used to capture maximum results, followed by keyword inclusion of “SLAP tear” and “biceps tenodesis.” Inclusion criteria included outcome studies of BT for isolated SLAP tear in athletes participating in any overhead sports, not limited to throwing alone. Abstracts and manuscripts were independently reviewed to determine eligibility. When clearly delineated, outcome variables from multiple studies were combined. Results: After full review, 8 articles met inclusion criteria (99 athletes; mean age, 19.8-47 years), with baseball and softball players the most common among them (n = 62). Type II SLAP tear was the most common diagnosis, and 0% to 44% of athletes had a failed previous SLAP repair before undergoing BT. Only 1 study included patients with concomitant rotator cuff repair. Open subpectoral BT was most commonly used, and complication rates ranged from 0% to 14%, with wound erythema, traumatic biceps tendon rupture, brachial plexus neurapraxia, and adhesive capsulitis being reported. Combined reported postoperative functional scores were as follows: American Shoulder and Elbow Surgeons, 81.7 to 97; 12-Item Short Form Health Survey physical, 50 to 54; visual analog scale for pain, 0.8-1.5; Kerlan Jobe Orthopaedic Clinic, 66 to 79; and satisfaction, 80% to 87%. The overall return-to-sports rate for overhead athletes was 70% (60 of 86). For studies that clearly delineated outcomes based on level of play/athlete, the combined return-to-sports rate was 69% (11 of 16) for recreational overhead athletes, 80% (4 of 5) for competitive/collegiate athletes, and 60% (18 of 30) for professionals. Conclusion: BT in the overhead athlete offers encouraging functional outcomes and return-to-sports rates, particularly in the recreational athlete. It can be successfully performed as an index operation rather than SLAP repair, as well as in a younger patient population. Careful consideration should be given to elite overhead athletes, particularly pitchers, who tend to experience poorer outcomes.
Management of Infantile Spasms During the COVID-19 Pandemic
Mytinger, John R. , Baumer, Fiona M. , Ciliberto, Michael A. , Cohen, Bruce H. , Dlugos, Dennis , Harini, Chellamani , Joshi, Sucheta M. , Keator, Cynthia, McGoldrick, Patricia E. , Nickels, Katherine , Park, Jun , Pasupuleti, Archana, Shahid, Asim, Shellhaas, Renée A. , Shrey, Daniel W. , Singh, Rani K. , Yozawitz, Elissa , Yuskaitis, Christopher J. , Waugh, Jeff L. , Baumer, Fiona M , Park, Jun T , Patel, Anup D , Singh, Rani K , Pearl, Phillip L , Shellhaas, Renée A , Yozawitz, Elissa G , Nickels, Katherine C , Grinspan, Zachary M. , Hussain, Shaun A. , Knupp, Kelly G. , Patel, Anup D. , Wolf, Steven M. , Pearl, Phillip L.

Mayo Clinic

Journal of Child Neurology | June 24, 2020 | Volume: 35 | Issue: 12 | Pages: 828-834

10.1177/0883073820933739 | PMID 32576057 Get It

Circumstances of the COVID-19 pandemic have mandated a change to standard management of infantile spasms. On April 6, 2020, the Child Neurology Society issued an online statement of immediate recommendations to streamline diagnosis and treatment of infantile spasms with utilization of telemedicine, outpatient studies, and selection of first-line oral therapies as initial treatment. The rationale for the recommendations and specific guidance including follow-up assessment are provided in this manuscript. These recommendations are indicated as enduring if intended to outlast the pandemic, and limited if intended only for the pandemic health care crisis but may be applicable to future disruptions of health care delivery.
Development and Validation of the Orthostatic Tremor Severity and Disability Scale (OT‐10)
Merola, Aristide , Torres‐Russotto, Diego , Stebbins, Glenn T. , Vizcarra, Joaquín A. , Shukla, Aparna Wagle, Hassan, Anhar , Elble, Rodger J. , Deuschl, Günther , Deuschl, Günther , Espay, Alberto J , Shukla, Aparna Wagle , Marsili, Luca , Krauss, Joachim Kurt , Espay, Alberto J.

Mayo Clinic

Movement Disorders | June 20, 2020 | Volume: 35 | Issue: 10 | Pages: 1796-1801

10.1002/mds.28142 | PMID 32562441 Get It

AbstractBackgroundLimited tools are available for the assessment of orthostatic tremor severity and disability.ObjectivesTo develop and validate a self‐administered orthostatic tremor scale.MethodsAfter expert consensus and literature review generating a list of 42 items, the scale was developed and modified for validation after a patient focus group, multiple rounds of Delphi panels, and cognitive interviews. Clinimetric evaluations included assessing content validity, internal consistency, measurement error and reliability, construct validity, and concurrent validity anchored on the examiner's Clinical Global Impression score.ResultsEleven items ranked on a Likert scale from 0 (no disability/severity) to 5 (maximal disability/severity) were evaluated in 54 orthostatic tremor patients (16 men and 38 women; mean age: 69.17 ± 9.64 years; disease duration: 13.83 ± 11.24 years) to probe severity and disability over the preceding 1‐week period. The 11‐item scale showed good internal consistency (Cronbach's alpha = 0.863) and acceptable (>0.40) item‐to‐total correlation. However, one item was removed at the final Delphi panel because of significant floor effect, poor item‐to‐total correlation, and poor factor‐loading, leaving the scale with 10 items (10‐item Orthostatic Tremor Severity and Disability Scale). Test‐retest reliability at 2 weeks was excellent (two‐way random intraclass correlation coefficient > 0.90), and the individual item test‐retest reliability showed good agreement, with a threshold weighted kappa >0.60 for all items. Exploratory factor analyses revealed a parsimonious two‐factor construct accounting for 57.7% of the scale's variance. The 10‐item Orthostatic Tremor Severity and Disability Scale scores correlated with the CGI.ConclusionsThe self‐administered 10‐item Orthostatic Tremor Severity and Disability Scale scale is valid and reliable for capturing orthostatic tremor–related severity and disability. © 2020 International Parkinson and Movement Disorder Society
The Disproportionate Impact of COVID-19 on Racial and Ethnic Minorities in the United States
Tai, Don Bambino Geno , Shah, Aditya , Sia, Irene G. , Wieland, Mark L. , Doubeni, Chyke A. , Wieland, Mark L , Tai, Don Bambino Geno , Sia, Irene G

Mayo Clinic

Clinical Infectious Diseases | June 15, 2020 | Volume: 72 | Issue: 4 | Pages: 703-706

10.1093/cid/ciaa815 | PMID 32562416 Get It

Abstract The coronavirus disease 2019 (COVID-19) pandemic has disproportionately affected racial and ethnic minority groups, with high rates of death in African American, Native American, and LatinX communities. Although the mechanisms of these disparities are being investigated, they can be conceived as arising from biomedical factors as well as social determinants of health. Minority groups are disproportionately affected by chronic medical conditions and lower access to healthcare that may portend worse COVID-19 outcomes. Furthermore, minority communities are more likely to experience living and working conditions that predispose them to worse outcomes. Underpinning these disparities are long-standing structural and societal factors that the COVID-19 pandemic has exposed. Clinicians can partner with patients and communities to reduce the short-term impact of COVID-19 disparities while advocating for structural change.
The Fistula Risk Score Catalog
Trudeau, Maxwell T. , Casciani, Fabio , Ecker, Brett L. , Seykora, Thomas F. , Puri, Priya , McMillan, Matthew T. , Miller, Benjamin C. , Pratt, Wande B., Asbun, Horacio J. , Ball, Chad G, Bassi, Claudio , Behrman, Stephen W. , Berger, Adam C. , Bloomston, Mark , Callery, Mark P., Castillo, Carlos Fernández‐del , Christein, John D. , Dillhoff, Mary , Dickson, Euan J., Dixon, Elijah , House, Michael G. , Hughes, Steven J. , Malleo, Giuseppe , Salem, Ronald R. , Wolfgang, Christopher L. , Vollmer, Charles M., Maggino, Laura , Ball, Chad G, Fisher, William P. , Kent, Tara Sotsky , Zureikat, Amer H.

Mayo Clinic

Annals of Surgery | June 15, 2020 | Volume: 275 | Issue: 2 | Pages: e463-e472

10.1097/sla.0000000000004068 | PMID 32541227 Get It

Objective: This study aims to present a full spectrum of individual patient presentations of pancreatic fistula risk, and to define the utility of mitigation strategies amongst some of the most prevalent, and vulnerable scenarios surgeons encounter. Background: The FRS has been utilized to identify technical strategies associated with reduced CR-POPF incidence across various risk strata. However, risk-stratification using the FRS has never been investigated with greater granularity. By deriving all possible combinations of FRS elements, individualized risk assessment could be utilized for precision medicine purposes. Methods: FRS profiles and outcomes of 5533 PDs were accrued from 17 international institutions (2003–2019). The FRS was used to derive 80 unique combinations of patient “scenarios.” Risk-matched analyses were conducted using a Bonferroni adjustment to identify scenarios with increased vulnerability for CR-POPF occurrence. Subsequently, these scenarios were analyzed using multivariable regression to explore optimal mitigation approaches. Results: The overall CR-POPF rate was 13.6%. All 80 possible scenarios were encountered, with the most frequent being scenario #1 (8.1%) – the only negligible-risk scenario (CR-POPF rate = 0.7%). The moderate-risk zone had the most scenarios (50), patients (N = 3246), CR-POPFs (65.2%), and greatest non-zero discrepancy in CR-POPF rates between scenarios (18-fold). In the risk-matched analysis, 2 scenarios (#59 and 60) displayed increased vulnerability for CR-POPF relative to the moderate-risk zone (both P < 0.001). Multivariable analysis revealed factors associated with CR-POPF in these scenarios: pancreaticogastrostomy reconstruction [odds ratio (OR) 4.67], omission of drain placement (OR 5.51), and prophylactic octreotide (OR 3.09). When comparing the utilization of best practice strategies to patients who did not have these conjointly utilized, there was a significant decrease in CR-POPF (10.7% vs 35.5%, P < 0.001; OR 0.20, 95% confidence interval 0.12–0.33). Conclusion: Through this data, a comprehensive fistula risk catalog has been created and the most clinically-impactful scenarios have been discerned. Focusing on individual scenarios provides a practical way to approach precision medicine, allowing for more directed and efficient management of CR-POPF.
The effect of using fecal testing after a negative sigmoidoscopy on the risk of death from colorectal cancer
Doubeni, Chyke A. , Corley, Douglas A. , Schottinger, Joanne E. , Lee, Jeffery K, Ghai, Nirupa R. , Levin, Theodore R. , Zhao, Wei , Saia, Chelsea , Wainwright, Jocelyn V. , Mehta, Shivan J. , Selby, Kevin , Doria‐Rose, V. Paul , Fletcher, Robert H., Saia, Chelsea A , Weiss, Noel S , Jensen, Christopher D. , Zauber, Ann Graham , Doubeni, Chyke A.

Mayo Clinic

Journal of Medical Screening | May 22, 2020 | Volume: 28 | Issue: 2 | Pages: 140-147

10.1177/0969141320921427 | PMID 32438892 Get It

Objective To examine whether receiving a fecal occult blood test after a negative sigmoidoscopy reduced mortality from colorectal cancer. Methods We used a nested case–control design with incidence-density matching in historical cohorts of 1,877,740 50–90-year-old persons during 2006–2012, in an integrated health-system setting. We selected 1758 average risk patients who died from colorectal cancer and 3503 matched colorectal cancer-free persons. Colorectal cancer-specific death was ascertained from cancer and mortality registries. Screening histories were determined from electronic and chart–audit clinical data in the 5- to 10-year period prior to the reference date. We evaluated receipt of subsequent fecal occult blood test within five years of the reference date among patients with negative sigmoidoscopy two to six years before the reference date. Results Of the 5261 patients, 831 patients (204 colorectal cancer deaths/627 controls) had either negative sigmoidoscopy only ( n = 592) or negative sigmoidoscopy with subsequent screening fecal occult blood test ( n = 239). Fifty-six (27.5%) of the 204 patients dying of colorectal cancer and 183 (29.2%) of the 627 colorectal cancer-free patients received fecal occult blood test following a negative sigmoidoscopy. Conditional regressions found no significant association between fecal occult blood test receipt and colorectal cancer death risk, overall (adjusted odds ratio = 0.93, confidence interval: 0.65–1.33), or for right (odds ratio = 1.02, confidence interval: 0.65–1.60) or left-colon/rectum (odds ratio = 0.77, confidence interval: 0.39–1.52) cancers. Similar results were obtained in sensitivity analyses with alternative exposure ascertainment windows or timing of fecal occult blood test. Conclusions Our results suggest that receipt of at least one fecal occult blood test during the several years after a negative sigmoidoscopy did not substantially reduce mortality from colorectal cancer.
Pancreaticobiliary Endoscopy in the COVID-19 Pandemic Era
Machicado, Jorge D. , Coté, Gregory A. , Wani, Sachin , Groce, J. Royce, Conwell, Darwin L. , Krishna, Somashekar G. , Krishna, Somashekar G , Papachristou, Georgios I.

Mayo Clinic

Pancreas | May 20, 2020 | Volume: 49 | Issue: 6 | Pages: 729-732

10.1097/mpa.0000000000001580 | PMID 32433265 Get It